References

Maria Kleppe, Kaitlyn Shank, Papalexi Efthymia, Hugh Y. Rienhoff, Ross L. Levine “Lysine-Specific Histone Demethylase, LSD1, (KDM1A) As a Novel Therapeutic Target in Myeloproliferative Neoplasms” Blood Dec 2015, 126 (23) 601

William J. Harris, Xu Huang, James T. Lynch, Gary J. Spencer, James R. Hitchin, Yaoyong Li, Filippo Ciceri, Julian G. Blaser, Brigit F. Greystoke, Allan M. Jordan, Crispin J. Miller, Donald J. Ogilvie, Tim C.P. Somervaille, “The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells” Cancer Cell, Volume 21, Issue 4, 17 April 2012, pp 473-487 doi: http://dx.doi.org/10.1016/j.ccr.2012.03.014

Alyson A. Lokken, Nancy J. Zeleznik-Le “Breaking the LSD1/KDM1A Addiction: Therapeutic Targeting of the Epigenetic Modifier in AML” Cancer Cell, Volume 21, Issue 4, 17 April 2012, pp 451-453 http://dx.doi.org/10.1016/j.ccr.2012.03.027

Danielle Simmons, “Epigenetic Influences and Disease.” Nature Education 1(1):6, 2008 http://www.nature.com/scitable/topicpage/epigenetic-influences-and-disease-895#